Physician profile
William Boss
NPI 1598769317
$488.32
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $72.35 · 2021: $87.45 · 2022: $41.46 · 2023: $148 · 2024: $29.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $133.38 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $85.69 | 2020-2023 | Collagenase Santyl |
| Axogen | $69.42 | 2019-2020 | |
| Allergan, INC. | $49.90 | 2019-2021 | |
| Kci USA, INC. | $40.57 | 2021-2022 | |
| Abbvie INC. | $29.15 | 2024 | |
| Endo Pharmaceuticals INC. | $28.39 | 2019-2020 | |
| Kerecis Limited | $24.13 | 2019 | |
| Galderma Laboratories, L.P. | $13.93 | 2021 | |
| Zimmer Biomet Holdings, INC. | $13.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Boss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.